Gastric Cancer

Knowledge is power. Are you facing a new diagnosis or recurrence of Gastric Cancer? The GI Connection Gastric Cancer Information Center has current, evidence-based information for you. Get the facts about the prevention, treatment, and living with Gastric Cancer. Stay up to date with news, tips, and features designed to keep you informed about the most recent developments and advances. learn more about Gastric Cancer

The GI Connection Gastric Cancer Community & Discussions

You are not alone—The GI Connection Community is the leading Social Media Application for individuals seeking information, inspiration, and support. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs. Login or register here.

GASTRIC CANCER NEWS TIPS & FEATURES

New Standard of Care for Treatment of Resectable Gastric Cancer

October 3rd, 2017

New Standard of Care for Treatment of Resectable Gastric Cancer

By Anonymous User anonymous_user_10987

The superiority of docetaxel based triplet therapy over standard care in patients with resectable esophago-gastric cancer has been confirmed in […]

View full entry

Tags: Esophageal Cancer, esophago-gastric cancer, Gastric Cancer, News Tips and Features, News Tips and Features Other


The US Food and Drug Administration has Expanded the Approval of the Precision Cancer Medicine Keytruda for Treatment of Gastric Cancer

September 25th, 2017

The US Food and Drug Administration has Expanded the Approval of the Precision Cancer Medicine Keytruda for Treatment of Gastric Cancer

By Anonymous User anonymous_user_10987

Keytruda (Pembrolizumab) is now indicated for patients with recurrent locally advanced or metastatic gastric or gastro-esophogeal junction adenocarcinoma. Patients eligible […]

View full entry

Tags: checkpoint inhibitor, Esophageal Cancer, Gastric Cancer, gastro-esophogeal junction cancer, keytruda, metastatic gastric, News Tips and Features, News Tips and Features Other, pembrolizumab, Precision Cancer Medicine


Keytruda Immunotherapy Appears Promising in Advanced Gastric Cancer

September 18th, 2017

Keytruda Immunotherapy Appears Promising in Advanced Gastric Cancer

By Anonymous User anonymous_user_10987

Keytruda (pembrolizumab) appears promising in patients with pretreated metastatic gastric cancer, according to late-breaking results from the KEYNOTE-059 trial presented […]

View full entry

Tags: Gastric Cancer, immunotherapy, KEYNOTE-059 programmed death-ligand 1, keytruda, metastatic gastric cancer, News Tips and Features, News Tips and Features Other, PD-L1, pembrolizumab, Precision Cancer Medicine, stomach cancer


Interim PET Scans May Improve Treatment for Esophageal Cancer

February 9th, 2017

Interim PET Scans May Improve Treatment for Esophageal Cancer

By cancerconnect cancerconnect

Clinical trial results presented at the 2017 Gastrointestinal Cancers Symposium in San Francisco suggest that the use of PET scans […]

View full entry

Tags: Esophageal Cancer, Gastric Cancer, News Tips and Features, News Tips and Features Other


Opdivo (nivolumab) Improves Survival in Patients with Advanced Gastric Cancer

February 6th, 2017

Opdivo (nivolumab) Improves Survival in Patients with Advanced Gastric Cancer

By Anonymous User anonymous_user_10987

At the 2017 Gastrointestinal Cancers Symposium in San Francisco researchers presented new trial results demonstrating that Opdivo (nivolumab) significantly reduced the risk […]

View full entry

Tags: Gastric Cancer, immunotherapy, News Tips and Features, News Tips and Features Other, nivolumab, Opdivo, precision medicine


Proton Beam Therapy May Improve Outcomes for Esophageal Cancer

January 23rd, 2017

Proton Beam Therapy May Improve Outcomes for Esophageal Cancer

By Anonymous User anonymous_user_10987

Currently a standard treatment for several gastrointestinal cancers (GI) combines the use of chemotherapy and radiation followed by surgical resection. […]

View full entry

Tags: Esophageal Cancer, Gastric Cancer, News Tips and Features, News Tips and Features Other, Pancreatic Cancer, proton beam therapy, Recurrent Gastric Cancer, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer, Stage IV/Recurrent Esophageal Cancer, Stages I-II Gastric Cancer, Stages I-III Esophageal Cancer


Should HER2 Testing Be Routinely Performed in Patients with Gastric Cancer?

December 8th, 2016

Should HER2 Testing Be Routinely Performed in Patients with Gastric Cancer?

By Anonymous User anonymous_user_10987

The short answer is yes! New evidence-based guidelines for human epidermal growth factor receptor 2 (HER2) testing in advanced gastric […]

View full entry

Tags: adenocarcinoma, American Society for Clinical Pathology, and American Society of Clinical Oncology, asco, ASCP, CAP, College of American Pathologists, Esophageal Cancer, for human epidermal growth factor receptor 2, Gastric Cancer, Gastroesophageal cancer, HER2 testing


More News →

CONDITIONS OF THE GI TRACT